Trial Profile
A Multicenter Non-Interventional Study Exploring the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With a Chemotherapy Combined With Bevacizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer; Muscular atrophy
- Focus Therapeutic Use
- Sponsors Roche
- 24 Mar 2020 Status changed from active, no longer recruiting to completed.
- 30 Oct 2019 Planned End Date changed from 31 Mar 2020 to 12 Mar 2020.
- 30 Oct 2019 Planned primary completion date changed from 31 Mar 2020 to 12 Mar 2020.